Search
for

    Sort by

    Research 181–210 of 1000+

    1. Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation International journal of cardiology · 2018 · 50 citations
    2. Testosterone implants in women: Pharmacological dosing for a physiologic effect Maturitas · 2012 · 21 citations
    3. Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome International Journal of Microbiology Research · 2023 · 15 citations
    4. Evaluation of efficacy, safety, and reversibility of combination regimen of cyproterone acetate and testosterone buciclate in bonnet monkey Contraception · 2000 · 4 citations
    5. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome Journal of ovarian research · 2023 · 1 citations
    6. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism 1978 · 8 citations
    7. Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men The Journal of Sexual Medicine · 2013 · 110 citations
    8. African Journal of Biomedical Research 2025
    9. Agaricus Subrufescens Ameliorates Ovarian Dysfunction and Regulates Altered Biochemical Parameters in Rats with Letrozole Induced Polycystic Ovarian Syndrome Research Square (Research Square) · 2023
    10. Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes Gynecological Endocrinology · 2015 · 9 citations
    11. Cutaneous Manifestations in Patients with Polycystic Ovary Syndrome: Their Prevalence and Correlation with Hormonal and Metabolic Parameters Zagazig University Medical Journal · 2025
    12. 8 Hair follicles and associated glands as androgen targets Clinics in endocrinology and metabolism · 1986 · 53 citations
    13. Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations The Journal of Clinical Endocrinology & Metabolism · 2020 · 12 citations
    14. Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats Naunyn-Schmiedeberg s Archives of Pharmacology · 2025
    15. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    16. The Safety of Testosterone Therapy in Women Journal of obstetrics and gynaecology Canada · 2012 · 11 citations
    17. The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial BMC endocrine disorders · 2023 · 2 citations
    18. Pharmacokinetics of Modified Slow-Release Oral Testosterone over 10 Days in Normal Men with Experimental Hypogonadism 2011
    19. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia Food and chemical toxicology · 2012 · 44 citations
    20. Increase in testosterone metabolism in the rat central nervous system by formalin-induced tonic pain Pharmacology Biochemistry and Behavior · 2002 · 11 citations
    21. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance Journal of Assisted Reproduction and Genetics · 2016 · 12 citations
    22. Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient Diabetes Therapy · 2022
    23. Evaluating Testosterone and Dehydroepiandrosterone Sulfate (DHEA-S) as Biomarkers for Male Androgenetic Alopecia East African Scholars Journal of Medical Sciences · 2025
    24. Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5α-reductase by finasteride International Journal of Andrology · 2010 · 10 citations
    25. Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels Recent Patents on Endocrine, Metabolic & Immune Drug Discovery · 2007 · 20 citations
    26. Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism* 1987 · 66 citations
    27. Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach toward postmenopausal hyperandrogenism European Journal of Obstetrics & Gynecology and Reproductive Biology · 2016 · 1 citations
    28. Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome Evidence Based Women Health Journal (Online) · 2016
    29. Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations? Gynecological Endocrinology · 1992 · 3 citations
    30. Is early onset androgenic alopecia a marker of metabolic syndrome and carotid artery atherosclerosis in young Indian male patients? International Journal of Trichology · 2015 · 24 citations